mesalamine has been researched along with Icterus in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, M | 1 |
| Najima, M | 1 |
| Morizane, C | 1 |
| Ueno, H | 1 |
| Okusaka, T | 1 |
| Nayar, M | 1 |
| Cunliffe, W | 1 |
| Cross, P | 1 |
| Oppong, K | 1 |
1 review available for mesalamine and Icterus
| Article | Year |
|---|---|
[Palliative therapy in patients with biliary tract cancer].
Topics: Abdominal Pain; Analgesics; Antineoplastic Agents; Back Pain; Biliary Tract Neoplasms; Drainage; Fee | 2006 |
1 other study available for mesalamine and Icterus
| Article | Year |
|---|---|
Mesalazine-induced jaundice, eosonophilia, and thrombocytopenia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Eosinophilia; Humans; Jaundice; Male; | 2008 |